The Coronavirus (COVID-19) lockdown checked the growth in sales of dermatologicals in Poland. The closure of shopping centres and sports facilities (swimming pools, gyms, fitness clubs) and restrictions on social contact limited exposure to many of the risk factors causing skin problems.
While the demand for dermatologicals is still rising in Poland, the pace of retail volume sales growth has slowed. This is partly due to still low consumer awareness, high market saturation and strong competition from dermocosmetics and even dietary supplements.
Dermatologicals in Poland is led by large international players, GSK Consumer Healthcare, Johnson & Johnson and Bayer, which benefit from broad brand portfolios. These companies also leverage brand/product familiarity and trust in other categories of consumer health.
COVID-19 is set to continue to impact the performance of dermatologicals in the short term, at least. This prediction has been consolidated by the spike in COVID-19 infections and hospitalisations in the country in October-November 2020.
A significant obstacle to the faster development of dermatologicals in Poland is the still low consumer awareness of skin issues and possible solutions. Skin testing in Poland remains at a low level, which inhibits OTC sales of dermatologicals.
Dermatologicals is expected to face stronger competition from dermocosmetics, which are becoming more and more popular among Polish consumers. Dermocosmetics are produced by global companies, but also small players, which sell their products via e-commerce.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Medicated Skin Care industry in Poland with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Medicated Skin Care industry in Poland, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Medicated Skin Care research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page